BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37909242)

  • 1. Inhibiting CSF1R alleviates cerebrovascular white matter disease and cognitive impairment.
    Askew KE; Beverley J; Sigfridsson E; Szymkowiak S; Emelianova K; Dando O; Hardingham GE; Duncombe J; Hennessy E; Koudelka J; Samarasekera N; Salman RA; Smith C; Tavares AAS; Gomez-Nicola D; Kalaria RN; McColl BW; Horsburgh K
    Glia; 2024 Feb; 72(2):375-395. PubMed ID: 37909242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline protects against microgliopathy in a Csf1r haplo-insufficient mouse model of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP).
    Li X; Hu B; Guan X; Wang Z; Zhou Y; Sun H; Zhang X; Li Y; Huang X; Zhao Y; Wang X; Xu H; Zhang YW; Wang Z; Zheng H
    J Neuroinflammation; 2023 May; 20(1):134. PubMed ID: 37259140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of microglia ameliorates white matter injury and cognitive impairment in a mouse chronic cerebral hypoperfusion model.
    Kakae M; Tobori S; Morishima M; Nagayasu K; Shirakawa H; Kaneko S
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1040-1044. PubMed ID: 31097227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration.
    Neal ML; Fleming SM; Budge KM; Boyle AM; Kim C; Alam G; Beier EE; Wu LJ; Richardson JR
    FASEB J; 2020 Jan; 34(1):1679-1694. PubMed ID: 31914683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy.
    Kempthorne L; Yoon H; Madore C; Smith S; Wszolek ZK; Rademakers R; Kim J; Butovsky O; Dickson DW
    Acta Neuropathol Commun; 2020 May; 8(1):72. PubMed ID: 32430064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of Nrf2 exacerbates white matter damage and microglia/macrophage levels in a mouse model of vascular cognitive impairment.
    Sigfridsson E; Marangoni M; Hardingham GE; Horsburgh K; Fowler JH
    J Neuroinflammation; 2020 Dec; 17(1):367. PubMed ID: 33261626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
    Olmos-Alonso A; Schetters ST; Sri S; Askew K; Mancuso R; Vargas-Caballero M; Holscher C; Perry VH; Gomez-Nicola D
    Brain; 2016 Mar; 139(Pt 3):891-907. PubMed ID: 26747862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characterization of a Csf1r haploinsufficient mouse model of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP).
    Chitu V; Gokhan S; Gulinello M; Branch CA; Patil M; Basu R; Stoddart C; Mehler MF; Stanley ER
    Neurobiol Dis; 2015 Feb; 74():219-28. PubMed ID: 25497733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
    Henry RJ; Ritzel RM; Barrett JP; Doran SJ; Jiao Y; Leach JB; Szeto GL; Wu J; Stoica BA; Faden AI; Loane DJ
    J Neurosci; 2020 Apr; 40(14):2960-2974. PubMed ID: 32094203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice.
    Dagher NN; Najafi AR; Kayala KM; Elmore MR; White TE; Medeiros R; West BL; Green KN
    J Neuroinflammation; 2015 Aug; 12():139. PubMed ID: 26232154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration.
    Obst J; Simon E; Martin-Estebane M; Pipi E; Barkwill LM; Gonzalez-Rivera I; Buchanan F; Prescott AR; Faust D; Fox S; Brownlees J; Taylor D; Perry VH; Nuthall H; Atkinson PJ; Karran E; Routledge C; Gomez-Nicola D
    Front Immunol; 2020; 11():579000. PubMed ID: 33162994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis.
    Uyar O; Laflamme N; Piret J; Venable MC; Carbonneau J; Zarrouk K; Rivest S; Boivin G
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colony-Stimulating Factor 1 Receptor (CSF1R) Regulates Microglia Density and Distribution, but Not Microglia Differentiation In Vivo.
    Oosterhof N; Kuil LE; van der Linde HC; Burm SM; Berdowski W; van Ijcken WFJ; van Swieten JC; Hol EM; Verheijen MHG; van Ham TJ
    Cell Rep; 2018 Jul; 24(5):1203-1217.e6. PubMed ID: 30067976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves.
    Martínez-Muriana A; Mancuso R; Francos-Quijorna I; Olmos-Alonso A; Osta R; Perry VH; Navarro X; Gomez-Nicola D; López-Vales R
    Sci Rep; 2016 May; 6():25663. PubMed ID: 27174644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early posttraumatic CSF1R inhibition via PLX3397 leads to time- and sex-dependent effects on inflammation and neuronal maintenance after traumatic brain injury in mice.
    Wang Y; Wernersbach I; Strehle J; Li S; Appel D; Klein M; Ritter K; Hummel R; Tegeder I; Schäfer MKE
    Brain Behav Immun; 2022 Nov; 106():49-66. PubMed ID: 35933030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF1R signaling is a regulator of pathogenesis in progressive MS.
    Hagan N; Kane JL; Grover D; Woodworth L; Madore C; Saleh J; Sancho J; Liu J; Li Y; Proto J; Zelic M; Mahan A; Kothe M; Scholte AA; Fitzgerald M; Gisevius B; Haghikia A; Butovsky O; Ofengeim D
    Cell Death Dis; 2020 Oct; 11(10):904. PubMed ID: 33097690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial loss of function of colony-stimulating factor 1 receptor in a patient with white matter abnormalities.
    Konno T; Miura T; Harriott AM; Mezaki N; Edwards ES; Rademakers R; Ross OA; Meschia JF; Ikeuchi T; Wszolek ZK
    Eur J Neurol; 2018 Jun; 25(6):875-881. PubMed ID: 29509319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen promotes white matter recovery and cognitive functions in male mice after chronic hypoperfusion.
    Chen Y; Tian Y; Tian H; Huang Q; Fang Y; Wang W; Wan Y; Pan D; Xie M
    Neurochem Int; 2019 Dec; 131():104566. PubMed ID: 31593788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting microglia proliferation after spinal cord injury improves recovery in mice and nonhuman primates.
    Poulen G; Aloy E; Bringuier CM; Mestre-Francés N; Artus EVF; Cardoso M; Perez JC; Goze-Bac C; Boukhaddaoui H; Lonjon N; Gerber YN; Perrin FE
    Theranostics; 2021; 11(18):8640-8659. PubMed ID: 34522204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter lesions, cerebral inflammation and cognitive function in a mouse model of cerebral hypoperfusion.
    Ben-Ari H; Lifschytz T; Wolf G; Rigbi A; Blumenfeld-Katzir T; Merzel TK; Koroukhov N; Lotan A; Lerer B
    Brain Res; 2019 May; 1711():193-201. PubMed ID: 30659829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.